In the third episode of “Startup Stereo,” our German Accelerator podcast, we invited two alumni of our Life Sciences program to talk about how they are involved in tackling the corona crisis. Daniel Mark is the Co-Founder and CEO of Spindiag, a diagnostics company involved in rapid testing for coronavirus infections. Oliver Uecke is the Head of Business Operations at Lipotype, a company providing lipid analysis services. They are certified to analyze samples infected with SARS-CoV-2 and are looking into the role lipidomics can play in coronavirus research. For the non-scientists among us, lipids are a diverse group of small molecules such as fatty acids or cholesterol amongst others!
In our conversation we dived deeper into how exactly their companies are involved in finding solutions for COVID-19, the impact of the whole situation on their companies such as for Spindiag it meant completely shifting their product from rapid testing for multi-resistant bacteria to testing for coronaviruses, and how they both perceive the “gold rush” in their field at the current moment.
German Accelerator’s “Startup Stereo” is a podcast with and for founders, innovators, and change-makers. Plug into the stories, experiences, and best practices around startups, expansion, leadership, new work, company culture, and more. Stay tuned for more episodes in the near future!